公开(公告)号：EP1239861A2

公开(公告)日：2002-09-18

申请号：EP00988905.6

申请日：2000-12-08

申请人： Aventis Pharma S.A.

发明人： DIB, Michel ,  LEPERLIER, Cyrille

IPC分类号： A61K31/55 ,  A61K31/54 ,  A61P25/00

CPC分类号： A61K31/54 ,  A61K31/55 ,  A61K31/505 ,  A61K31/495 ,  A61K31/445 ,  A61K2300/00

摘要： The invention concerns the combination of cyamemazine and an atypical neuroleptic or one of their pharmaceutically acceptable salts and its use for treating schizophrenia and, in particular acute episodes of schizophrenia.

公开(公告)号：EP1239861B1

公开(公告)日：2007-04-04

申请号：EP00988905.6

申请日：2000-12-08

申请人： Aventis Pharma S.A.

发明人： DIB, Michel ,  LEPERLIER, Cyrille

IPC分类号： A61K31/55 ,  A61K31/54 ,  A61P25/00

CPC分类号： A61K31/54 ,  A61K31/55 ,  A61K31/505 ,  A61K31/495 ,  A61K31/445 ,  A61K2300/00

摘要： The invention concerns the combination of cyamemazine and an atypical neuroleptic or one of their pharmaceutically acceptable salts and its use for treating schizophrenia and, in particular acute episodes of schizophrenia.